New investment in production of powders

Silab is commissioning its new powder production unit on its site. The company selected the spray-drying technology to transform its active ingredients into a dry form, marketed without preservatives.

Commissioned in September 2019, this production plant complies with the pharmaceutical Good manufacturing practices (GMP). This guarantee, combined with highly innovative process engineering and packaging in controlled-atmosphere areas, enables production of powders with stringent bacteriological standards.


Xavier Gaillard, deputy general manager for Strategy, said: “We are proud of having carried out this major project that required an investment of €11 million and that was supported by the European Union, the French government, the Nouvelle-Aquitaine region, and the Corrèze departmental council. Bringing this production technology in house will allow us to offer our active ingredients in preservative-free powderform. This fits into a strategy of diversifying our cosmetics offerings (Silab Cosmetics), while meeting the current expectations of medicalizing skin care (Silab Softcare).”

The project led to the creation of several jobs (around ten expected in the long term) and the development of new skills in house.

See more about SILAB